Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
89.05 CHF | +0.20% | +1.93% | +4.93% |
Apr. 30 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
Apr. 30 | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
Sales 2024 * | 48.82B 44.96B | Sales 2025 * | 50.64B 46.64B | Capitalization | 198B 183B |
---|---|---|---|---|---|
Net income 2024 * | 10.22B 9.41B | Net income 2025 * | 11.93B 10.98B | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 12.78B 11.77B | Net Debt 2025 * | 11.31B 10.41B | EV / Sales 2025 * | 4.14 x |
P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
16.6
x | Employees | 76,057 |
Yield 2024 * |
3.72% | Yield 2025 * |
3.85% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | +0.20% | ||
1 week | +1.93% | ||
Current month | +1.92% | ||
1 month | +1.92% | ||
3 months | -4.15% | ||
6 months | +6.32% | ||
Current year | +4.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 18 M€ | +2.91% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 89.05 | +0.20% | 2,925,672 |
24-04-29 | 88.87 | -0.70% | 2,820,456 |
24-04-26 | 89.5 | -0.56% | 3,249,537 |
24-04-25 | 90 | +0.99% | 4,571,037 |
24-04-24 | 89.12 | +0.20% | 3,572,943 |
Delayed Quote Swiss Exchange, April 30, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.93% | 198B | |
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
-9.78% | 194B | |
-4.89% | 147B | |
-11.01% | 145B |
- Stock Market
- Equities
- NOVN Stock